Loading…

Biphenyl-Derived Phosphepines as Chiral Nucleophilic Catalysts: Enantioselective [4+1] Annulations To Form Functionalized Cyclopentenes

Because of the frequent occurrence of cyclopentane subunits in bioactive compounds, the development of efficient catalytic asymmetric methods for their synthesis is an important objective. Introduced herein is a new family of chiral nucleophilic catalysts, biphenyl‐derived phosphepines, and we apply...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie 2014-11, Vol.126 (48), p.13399-13403
Main Authors: Ziegler, Daniel T., Riesgo, Lorena, Ikeda, Takuya, Fujiwara, Yuji, Fu, Gregory C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Because of the frequent occurrence of cyclopentane subunits in bioactive compounds, the development of efficient catalytic asymmetric methods for their synthesis is an important objective. Introduced herein is a new family of chiral nucleophilic catalysts, biphenyl‐derived phosphepines, and we apply them to an enantioselective variant of a useful [4+1] annulation. A range of one‐carbon coupling partners can be employed, thereby generating cyclopentenes which bear a fully substituted stereocenter [either all‐carbon or heteroatom‐substituted (sulfur and phosphorus)]. Stereocenters at the other four positions of the cyclopentane ring can also be introduced with good stereoselectivity. An initial mechanistic study indicates that phosphine addition to the electrophilic four‐carbon coupling partner is not the turnover‐limiting step of the catalytic cycle. Eine ganze Familie neuer chiraler nucleophiler Katalysatoren – Phosphepine mit Biphenylrückgrat – wurde in der Titelreaktion eingesetzt. Umsetzungen einer Reihe von C1‐Kupplungspartnern ergaben Cyclopentene mit einem vollständig substituierten Stereozentrum. Erste mechanistische Studien werden beschrieben.
ISSN:0044-8249
1521-3757
DOI:10.1002/ange.201405854